Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

Fig. 1

Metabolic, endocrine and inflammatory parameters on day 0 compared between STF and non-STF subjects. Values are measured on day 0 immediately before chemotherapy infusion (during the use of prophylactic dexamethasone). Mean values of different patients of different cycles (1–6) are combined to test differences between both treatment groups. * P value <0.05. Reference values: glucose 3.1-6.4 mmol/L; insulin 0-20 mU/L; IGF-1 5.4-24.3 nmol/L; IGF-BP3 2.2-5.8 mg/L; TSH 0.3-4.8 mU/L; FT412-22pmol/L, T31.1-3.1 nmol/L; CRP 0.0-5.0 mg/L;. IGF-1; Abbreviations: STF: short-term fasting, IGF-1:Insulin-like growth factor 1, IGF-BP3: insulin- like growth factor binding protein 3, TSH: thyroid-stimulating hormone; FT4:,free thyroxine; T3: CRP; C-reactive protein

Back to article page